Hyperbaric Oxygen Therapy, Explained Clearly.

Fertility · IVF · Male Fertility · HBOT Research · 8 Min Read HBOT & Fertility: What Does the Research Actually Show? Interest in Hyperbaric Oxygen Therapy and fertility is growing — but the most interesting development is not a broad claim that HBOT can simply “boost fertility”. Researchers are now studying HBOT in specific reproductive contexts, including resistant thin endometrium, poor ovarian response and male infertility. That gives us something much more useful to examine: what has actually happened in human fertility studies? Explore the Fertility Research ↓ In This Article Why oxygenation is being investigated Thin endometrium & IVF research Poor ovarian response research Male fertility research What does the evidence mean? How ReWell approaches fertility Accessing HBOT Common questions The Science Why Is Oxygenation Being Investigated in Fertility? Reproductive biology is complex. Fertility cannot be reduced to one hormone, one organ or one physiological process. What researchers do know is that reproductive tissues depend on blood supply, oxygen delivery, cellular energy and the surrounding tissue environment. HBOT changes oxygen availability in a distinctive way. The HBOT Effect Increased Atmospheric Pressure + Oxygen↓More Oxygen Dissolved in Blood Plasma↓Increased Oxygen Availability During Treatment↓A Physiological Environment Researchers Can Study in Reproductive Tissues This has led researchers to investigate whether repeated HBOT exposure could influence specific reproductive parameters rather than assuming it has one universal effect on fertility. Tissue Oxygenation Increased dissolved plasma oxygen creates a temporary increase in oxygen availability throughout the body. Blood Supply Vascular and tissue responses are particularly relevant when researchers are investigating endometrial development and implantation environments. Cellular Function Oxygen is central to cellular energy production, making metabolic responses another area of interest in reproductive research. These mechanisms explain why HBOT is worth investigating. The research tells us whether measurable reproductive outcomes have actually changed. The Human Research Thin Endometrium & Frozen Embryo Transfer One of the most interesting human studies looked at a very specific fertility challenge: resistant thin endometrium during frozen embryo transfer treatment. Thin endometrium can make embryo implantation more difficult and may lead to cancelled transfer cycles when adequate endometrial thickness cannot be achieved. 2023 Prospective Study · Resistant Thin Endometrium Endometrial Thickness Increased After HBOT The study involved women who had previously experienced at least one cancelled frozen embryo transfer cycle because their endometrium remained below 7 mm despite standard and additional therapies. Participants receiving HBOT underwent daily treatment for at least 10 days during the proliferative phase alongside their routine endometrial preparation. Following HBOT, average endometrial thickness increased from 5.76 mm to 6.57 mm, a statistically significant change. 5.76 → 6.57 mm Significant increase in endometrial thickness Fewer Cancellations Cycle cancellation rate decreased after HBOT Blastocyst Group Higher intrauterine pregnancy rate reported Among participants receiving blastocysts, the intrauterine pregnancy rate was 53.8% in the HBOT group compared with 18.2% in the concurrent control group. The same difference was not seen among participants receiving cleavage-stage embryos. This is an encouraging fertility-specific finding, particularly because the study investigated women with a defined clinical challenge rather than fertility in general. View the study on PubMed → 2025 Research What About Poor Ovarian Response? A different 2025 study investigated HBOT in women classified as poor ovarian responders — another specific challenge encountered during assisted reproduction. The pre-post cohort included 41 women aged 20–45 and compared ovarian stimulation outcomes before and after HBOT. Researchers reported increases in the number of oocytes retrieved, normally fertilised oocytes and available embryos after HBOT. They also reported improvements in measures including follicle output rate and the available embryo rate. Interestingly, their analysis suggested oocyte numbers increased after two HBOT sessions, plateaued around four to seven sessions and did not show further increases beyond eight sessions. This gives researchers a useful signal to investigate further — but because this was a pre-post cohort rather than a large randomised controlled trial, confirmation in stronger controlled studies is still needed. View the 2025 study on PubMed → Male Fertility HBOT Research Is Not Limited to Female Fertility Fertility is a shared picture, and research into HBOT has also examined male reproductive parameters. A 2025 systematic review and meta-analysis brought together randomised controlled trials investigating HBOT for male infertility. 2025 Systematic Review & Meta-Analysis · 9 Trials Several Sperm Parameters Improved Nine eligible studies were included in the analysis. The researchers reported statistically significant improvements across several measures of sperm quality following HBOT, including: Motility Improvement reported Density Improvement reported Viability Improvement reported Morphology Improvement reported Normal Sperm Rate Improvement reported Clinical Pregnancy Higher rate reported HBOT was evaluated alongside conventional treatment rather than as a replacement for standard fertility care. The authors considered the findings promising, while also highlighting the relatively small number of available trials and the possibility of publication bias. View the systematic review on PubMed → The fertility research becomes much more useful when we stop asking whether HBOT simply “boosts fertility” and start asking which reproductive parameters researchers have actually measured. Understanding the Evidence Three Different Research Areas. Three Different Questions. These studies should not be bundled together into a claim that HBOT has been proven to improve fertility for everyone. What they show is more specific — and more interesting. In women with resistant thin endometrium, researchers have reported increased endometrial thickness and encouraging implantation findings in a blastocyst subgroup. In women with poor ovarian response, a recent cohort reported increases in oocyte yield and embryo-related measures. In male infertility, a meta-analysis of nine trials found improvements across multiple sperm parameters and clinical pregnancy rate when HBOT was combined with conventional treatment. Together, these studies give fertility-specific HBOT research a meaningful foundation. They also make it clear that the reason someone is considering HBOT matters. At ReWell HBOT Should Fit Around Your Fertility Journey There is no single fertility journey — and there should not be a single HBOT conversation either. Someone trying naturally has a different situation from someone preparing for IVF. Someone experiencing poor ovarian response has different questions from a couple investigating male-factor infertility. At ReWell, the starting point is understanding where you are in that journey and why you are considering HBOT. Trying Naturally Your wider fertility history, health and goals provide the context for any additional support being considered. Preparing for IVF HBOT should be considered around the timing and recommendations of the fertility treatment already underway. Specific Fertility Challenges Where thin endometrium, poor ovarian response or male-factor infertility is relevant, the research can be discussed in that specific context. If you are undergoing IVF, taking fertility medication or working with a fertility specialist, ReWell recommends discussing additional therapies and supplements with that team. Explore HBOT & Fertility at ReWell → Beyond HBOT Looking for Wider Fertility Support? ReWell's Fertility Support service is separate from HBOT and takes a wider look at your individual fertility journey. Depending on your circumstances, that may include personalised nutrition, lifestyle support, relevant testing and other supportive strategies around natural conception, IVF preparation or a longer fertility journey. Explore Personalised Fertility Support → HBOT Access Explore HBOT Around Your Fertility Plan Depending on where you live, the frequency being considered and your wider fertility plan, ReWell offers clinic, home rental and ownership options. Try Start With a Clinic Session New to HBOT? Experience an introductory session at ReWell in Naas, Co. Kildare and talk through what is involved. 60 minute session €85 incl. VAT Book an HBOT Session → Rent Regular HBOT at Home Research protocols frequently involve repeated sessions. Home rental can make regular access more practical by removing repeated travel to the clinic. From €1,229/month incl. VAT Explore Home HBOT Rental → Own Long-Term HBOT Access ReWell also supplies soft-shell and hard-shell hyperbaric chambers for people who want longer-term access at home. From €9,999 excl. VAT Explore HBOT Chambers → If you decide to purchase later, up to six months of eligible ReWell rental payments can be credited towards your chamber purchase. Personalised Guidance Talk Through Your HBOT Options With Davitt ReWell's HBOT programmes are guided by Davitt Meenaghan, IBUM-certified Hyperbaric Safety Officer. “With fertility, context matters. We want to understand where you are in your journey, what treatment or support is already in place and why you are considering HBOT before talking about how it could fit.” Davitt can talk you through the research, screening, chamber options, pressure, practical access and how HBOT may fit around your wider fertility plan. Talk to Davitt — Book a Free Discovery Call → Keep Exploring Fertility, Research & ReWell HBOT & Fertility Explore how HBOT is being researched around fertility, IVF and reproductive health. Explore HBOT & Fertility → Fertility Support Explore ReWell's separate personalised service covering nutrition, lifestyle and wider fertility support. Explore Fertility Support → HBOT Research Hub Explore published research across fertility, recovery, neurological health, chronic pain and other areas. Visit the Research Hub → Common Questions HBOT & Fertility FAQs Has HBOT actually been studied for fertility? Yes. Human research has examined HBOT in several specific fertility contexts, including resistant thin endometrium during frozen embryo transfer, poor ovarian response and male infertility. The evidence base is still developing, but it now includes prospective clinical research, cohort studies and a systematic review and meta-analysis of male infertility trials. Can HBOT improve endometrial thickness? A 2023 prospective study involving women with resistant thin endometrium reported a statistically significant increase in average endometrial thickness after HBOT, from 5.76 mm to 6.57 mm. The study also reported fewer cancelled cycles. Has HBOT been studied during IVF? Yes. Research has investigated HBOT in specific assisted-reproduction settings, including resistant thin endometrium during frozen embryo transfer and poor ovarian response during controlled ovarian stimulation. These findings should be interpreted in the context of the specific patient groups studied rather than applied to every IVF cycle. Does HBOT improve egg quality? It is more accurate to describe what the research measured rather than make a general claim about “egg quality”. A 2025 pre-post study in poor ovarian responders reported increases in oocyte numbers, normally fertilised oocytes and available embryos, along with improvements in several ovarian-response and embryo-related measures. Larger controlled studies are needed to confirm these findings. Has HBOT been studied for male infertility? Yes. A 2025 systematic review and meta-analysis of nine trials reported improvements in sperm viability, density, morphology, normal sperm rates and motility, as well as an increased clinical pregnancy rate when HBOT was combined with conventional treatment. Can HBOT replace IVF or fertility treatment? No. The studies discussed here investigate HBOT in specific reproductive settings, often alongside conventional fertility treatment. HBOT does not replace appropriate fertility assessment, IVF, medication or specialist reproductive care. Should I tell my fertility clinic if I am considering HBOT? Yes. If you are undergoing IVF, using fertility medication or receiving specialist fertility care, ReWell recommends discussing additional therapies and supplements with your fertility team so that your wider plan remains coordinated. The Bottom Line The Fertility Research Is Becoming More Specific — and That Matters The strongest reason to pay attention to HBOT and fertility is not because oxygen sounds intuitively “good for fertility”. It is because researchers are beginning to test HBOT against specific reproductive challenges and measurable outcomes. We now have human research examining resistant thin endometrium, ovarian response, oocyte and embryo measures, sperm parameters and clinical pregnancy outcomes. These are encouraging areas of investigation. They are also different clinical questions, and the research is at different stages of development. The useful question is not “Does HBOT boost fertility?” It is “What part of the fertility journey are we trying to understand — and what does the research show there?” Explore Your Options Could HBOT Have a Place in Your Fertility Journey? Explore the fertility-specific research, learn more about HBOT at ReWell or talk with Davitt about your circumstances and the practical options for accessing HBOT. Explore HBOT & Fertility Fertility Support Talk to Davitt This article is for general educational purposes and does not constitute medical or fertility advice. HBOT is not a replacement for fertility assessment, IVF, medication or specialist reproductive care. If you are undergoing fertility treatment, discuss additional therapies with your fertility team. HBOT may not be suitable for everyone, and screening and individual suitability matter before treatment.

The ReWell Guide to HBOT Hyperbaric Oxygen Therapy (HBOT): A Complete Guide to How It Works, Benefits, Research & Safety What actually happens inside a hyperbaric chamber? Why does pressure matter? And what does the research really tell us? This guide brings together the science, practical considerations and different ways to access Hyperbaric Oxygen Therapy in Ireland. ReWell Ireland Updated September 2026 Evidence-Aware Guide Clinic Sessions in Naas Home Rental Nationwide Own Chambers From €9,999 + VAT 32 Counties Nationwide Support Start Here What Is Hyperbaric Oxygen Therapy? At its simplest, hyperbaric therapy combines increased atmospheric pressure with increased oxygen availability. A person sits or lies inside a purpose-built chamber while the pressure inside the chamber is gradually increased above normal atmospheric pressure. Depending on the type of chamber and protocol, oxygen may be delivered at different concentrations. The combination of pressure and oxygen changes the physical behaviour of oxygen in the body. In traditional medical HBOT, breathing high-concentration oxygen under pressure substantially increases the amount of dissolved oxygen carried in the blood plasma, in addition to the oxygen already transported by haemoglobin. HBOT is not simply about “breathing more oxygen”. Pressure is a fundamental part of the process because it changes how oxygen is dissolved and delivered within the body. In This Guide How does HBOT work? What happens in the body? Benefits & research Understanding ATA Soft-shell vs hard-shell What happens during a session? How many sessions? Safety & contraindications Clinic, rental or ownership? Frequently asked questions The Fundamentals How Does HBOT Work? HBOT works through two connected variables: pressure and oxygen. Increasing atmospheric pressure affects gases in the body, while increasing the partial pressure of oxygen changes the amount of oxygen available in blood and tissues. 1 Pressure Increases The chamber is gradually pressurised above normal atmospheric pressure. This controlled increase in pressure is measured in atmospheres absolute, or ATA. 2 Oxygen Availability Rises Under appropriate hyperbaric conditions, more oxygen can dissolve into the liquid component of the blood, increasing oxygen availability beyond that carried by haemoglobin alone. 3 Tissue Oxygen Changes Where blood flow is sufficient to deliver that oxygen, tissue oxygen levels can rise. These changes form part of the physiological basis for established and developing applications of HBOT. Hyperbaric chambers are available in different formats, pressure ranges and configurations. Inside the Body What Happens to the Body During HBOT? The science of HBOT extends beyond simply supplying oxygen. Research into hyperbaric physiology describes several interconnected effects produced by pressure, increased oxygen partial pressure and the body's response to those changes. More Dissolved Oxygen Under hyperbaric conditions, oxygen can dissolve into plasma at higher concentrations. This increases the amount of oxygen available for delivery through the circulation. Higher Tissue Oxygen Increased oxygen availability in the circulation can raise tissue oxygen levels where perfusion is sufficient to deliver it. Cellular Signalling Hyperoxia influences reactive oxygen and nitrogen species. In controlled amounts these molecules also participate in cell-signalling pathways associated with physiological adaptation and repair processes. Repair & Vascular Processes Research has examined HBOT in relation to growth-factor signalling, wound repair and angiogenesis — the formation of new blood vessels — particularly in areas where HBOT already has established medical uses. Benefits & Evidence What Is HBOT Used For? This is where it is important to separate established medical applications from areas where research is still developing. Hyperbaric oxygen has recognised clinical applications in conventional hyperbaric medicine. These include conditions such as decompression sickness, carbon monoxide poisoning, selected problem wounds, delayed radiation injury, refractory osteomyelitis and certain other specific conditions. At the same time, researchers continue to investigate HBOT across a much broader range of areas. The strength of evidence varies considerably by condition, treatment pressure, oxygen concentration, protocol and patient population. Recovery & Tissue Repair HBOT research includes wound healing, tissue oxygenation, post-surgical recovery and repair processes. The quality of evidence depends heavily on the particular condition being studied. Explore Recovery → Sport & Performance Recovery Research is examining whether hyperbaric exposure may have a role in exercise recovery, muscle recovery and selected sports-related injuries. It should not be presented as proven to prevent injury or guarantee faster return to play. Explore Athletic Recovery → Brain & Neurological Research HBOT is being studied in areas involving brain metabolism, neuroplasticity, traumatic brain injury and post-concussion symptoms. Findings vary between conditions and study protocols. Explore Brain & Concussion Research → Long COVID & Post-Viral Symptoms Emerging human studies have explored HBOT in relation to cognition, fatigue, quality of life and other persistent symptoms following COVID-19. This remains an evolving area of research. Explore Long COVID → Chronic Pain & Fibromyalgia Research has explored HBOT in fibromyalgia and chronic pain populations, including possible effects involving pain processing, cellular metabolism and inflammatory pathways. Explore Chronic Pain → Healthy Ageing & Longevity HBOT is also being researched in relation to aspects of ageing biology and cognitive function. These findings are interesting, but they should not be interpreted as evidence that HBOT reverses ageing or extends lifespan. Explore the Research → The Science We can explain with reasonable confidence what increased pressure and oxygen do physiologically: they alter oxygen partial pressure, increase dissolved oxygen under appropriate conditions and influence cellular signalling and tissue oxygenation. The Research Whether those mechanisms translate into a meaningful clinical benefit depends on the condition, the individual and the treatment protocol. That is why ReWell looks at condition-specific human research rather than treating every proposed use of HBOT as equally established. Understanding Pressure What Does ATA Mean in Hyperbaric Therapy? Hyperbaric chamber pressure is normally described in ATA — atmospheres absolute. Normal atmospheric pressure at sea level is approximately 1.0 ATA. A chamber operating above this increases the pressure around the body. You may see chambers described as 1.3 ATA, 1.5 ATA, 2.0 ATA or 2.5 ATA. These numbers matter — but a higher number does not automatically mean a better treatment. Pressure Broad Context 1.3 ATA Lower-pressure or mild hyperbaric exposure. 1.5 ATA Common in some lower-pressure soft-shell and wellness settings. 2.0 ATA Higher-pressure hyperbaric exposure available in suitable hard-shell systems. 2.5 ATA Higher-pressure protocols requiring appropriate equipment, training and safety oversight. Pressure is only one part of a protocol. Oxygen concentration, session duration, frequency, chamber type and the reason for using HBOT all matter. Read our guide to HBOT pressure → Chamber Types Soft-Shell vs Hard-Shell Hyperbaric Chambers Hyperbaric chambers are not all the same. One of the most important practical distinctions is between lower-pressure soft-shell systems and hard-shell chambers capable of operating at higher pressures. Portable chamber formats can make regular home access more practical for suitable users. Soft-Shell Chambers Soft-shell chambers are portable systems generally designed for lower-pressure hyperbaric use. Their size, installation requirements and accessibility make them particularly relevant for home rental and ownership. ReWell offers lying/hybrid, seated and accessible soft-shell options, allowing the chamber format to be matched more closely to the person, household and available space. Hard-Shell Chambers Hard-shell chambers use rigid construction and can operate at higher pressures. Depending on the model, these may be appropriate for private, professional, clinic, sports, recovery or wellness settings where the required installation, operational and safety considerations can be met. The right choice is therefore not simply “soft or hard”. It depends on why you are considering HBOT, how frequently it will be used, required pressure, space, mobility, budget and the level of operational support required. Compare soft-shell and hard-shell chambers → What to Expect What Happens During an HBOT Session? Although chamber types differ, the basic experience follows a similar pattern. You enter the chamber, the pressure is gradually increased, you spend the prescribed period at pressure, and the chamber is then slowly depressurised. During pressurisation, your ears may feel similar to how they feel during take-off or landing in an aircraft. You will normally be shown techniques for equalising pressure in your ears before beginning. Once at pressure, the experience is generally passive. Depending on the chamber, you may sit or lie down and relax for the duration of the session. HBOT protocols are not one-size-fits-all. Session pressure, duration, frequency and total number of sessions should be considered in the context of the individual and the reason HBOT is being used. See what to expect at your first session → Your Programme How Many HBOT Sessions Do You Need? There is no universal number of HBOT sessions that is right for everyone. Some established medical protocols involve defined treatment schedules. Outside those settings, the appropriate frequency and duration depend on the purpose of treatment, chamber pressure, individual circumstances, response and the evidence relevant to the particular condition. This is one reason ReWell places emphasis on a personalised programme rather than simply selling individual chamber sessions or assuming that the same schedule is appropriate for every person. For people who are likely to use HBOT regularly, home rental can also remove some of the practical barriers involved in repeatedly travelling to a clinic. Read the full session guide → Safety First Is Hyperbaric Oxygen Therapy Safe? HBOT is generally well tolerated when the person, equipment and protocol are appropriate, but it is not risk-free. Pressure and elevated oxygen exposure create specific safety considerations that should be understood before treatment begins. Ear & Sinus Pressure Pressure-related ear discomfort and barotrauma are among the more common adverse effects. Proper equalisation and controlled pressurisation are important. Oxygen Exposure Higher oxygen exposures can produce oxygen-related adverse effects. Appropriate pressure, duration and protocol selection therefore matter. Suitability Screening Untreated pneumothorax is a recognised absolute contraindication. Medications, respiratory conditions, recent surgery, pregnancy and other medical circumstances may also require individual assessment. Chamber Safety Oxygen and pressurised environments require strict attention to ignition sources, electronics, batteries, clothing, equipment and manufacturer operating procedures. Read ReWell's HBOT Safety & Clinical Standards → Accessing HBOT in Ireland Try It. Rent It. Or Own Your Chamber. ReWell offers three ways to access HBOT, allowing you to start at the level that makes sense for your circumstances rather than committing to one route from the beginning. Try First From €85 incl. VAT Start with an introductory HBOT session at the ReWell clinic in Naas, Co. Kildare and experience a chamber before deciding what comes next. Explore Clinic Sessions → Rent at Home From €1,229 / month incl. VAT Access HBOT more regularly at home with chamber rental available across all 32 counties. Eligible rental payments can be credited towards a later purchase for up to six months. Explore Chamber Rental → Own From €9,999 excl. VAT For individuals, families and professional settings wanting longer-term access, ReWell offers a range of soft-shell and hard-shell chamber options with delivery, installation and ongoing guidance. Explore Chamber Ownership → Personally Guided Not Sure Where to Start? Davitt Meenaghan · IBUM-Certified Hyperbaric Safety Officer Choosing HBOT is not just about choosing a chamber. Pressure, oxygen delivery, frequency, chamber type, safety and your reason for considering HBOT all need to make sense together. Davitt can talk you through the available options and help you understand whether clinic sessions, home rental or ownership is the most appropriate place to begin. Speak With Davitt → Selected References Research Behind the Fundamentals This guide is designed as an accessible introduction rather than an exhaustive systematic review. These sources provide useful background on HBOT mechanisms, clinical applications and safety. Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41(3):247–252. PMID 24984320 → Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011. PMID 21200283 → Zhang Y et al. Adverse effects of hyperbaric oxygen therapy: a systematic review and meta-analysis. Front Med. 2023. PMID 37275378 → Undersea & Hyperbaric Medical Society. Hyperbaric Oxygen Therapy Indications. View UHMS Indications → Frequently Asked Questions HBOT: The Practical Questions Is HBOT the same as simply breathing oxygen? No. Hyperbaric therapy involves increased atmospheric pressure. The combination of pressure and oxygen exposure changes oxygen partial pressure and, under appropriate conditions, increases the amount of oxygen dissolved in plasma. Does a higher ATA mean better HBOT? No. Higher pressure is not automatically better. The appropriate pressure depends on the chamber, oxygen delivery, intended use, protocol and individual circumstances. Can I have a hyperbaric chamber at home? Yes, suitable hyperbaric chambers can be installed for home use. The right option depends on chamber type, available space, accessibility, oxygen equipment, power requirements, safety and how frequently you plan to use it. ReWell provides home chamber rental across Ireland as well as ownership options. How much does HBOT cost in Ireland? At ReWell, a new-client introductory clinic session starts from €85 incl. VAT. Home chamber rental starts from €1,229 incl. VAT per month, while chamber ownership starts from €9,999 excl. VAT. Pricing varies according to the chamber and access option. How many HBOT sessions will I need? There is no single answer. Session number and frequency depend on the reason for using HBOT, the protocol, chamber pressure, individual circumstances and response. Some people use a defined course, while others are considering more regular access. Is HBOT proven for every condition it is used for? No. HBOT has established medical indications, while many other areas are still being investigated. Evidence quality varies considerably by condition. ReWell separates established physiology from condition-specific research so that emerging evidence is not presented as established fact. Who should not use HBOT? Untreated pneumothorax is a recognised absolute contraindication. Other medical conditions, medications, pregnancy, recent procedures and individual circumstances may require additional assessment before HBOT. Suitability should always be considered before beginning. The Bottom Line HBOT Is Simple in Principle — But the Details Matter Pressure changes oxygen availability. What matters next is how that physiology is applied. Hyperbaric Oxygen Therapy has established uses within medicine and a growing body of research across recovery, neurological health, persistent symptoms, sports and other areas. But the evidence is not equally strong for every proposed application. Understanding the difference between the mechanism, the research and the practical protocol is the best place to start. At ReWell, that also means looking beyond the chamber itself — at suitability, pressure, oxygen, frequency, safety and whether clinic access, home rental or ownership best fits what you are trying to achieve. Wondering Whether HBOT Is Right for You? Speak with Davitt about your goals, the different chamber options and the most practical way to access HBOT through ReWell. Book a Discovery Call Explore Home Rental This article is for general educational information only and is not medical advice, diagnosis or treatment. HBOT has established medical applications as well as areas where research is still developing. Individual suitability, potential benefits and risks vary. Speak with an appropriately qualified healthcare professional regarding medical conditions or treatment decisions.

Red Light Therapy · Photobiomodulation What Is Red Light Therapy? A Practical Guide to Photobiomodulation Red light therapy is everywhere — in clinics, recovery centres, beauty devices and home wellness products. But the science is more specific than simply “shining red light” on the body. Photobiomodulation uses particular wavelengths and doses of red or near-infrared light to influence biological activity in tissue. ReWell Ireland · Updated September 2026 · Evidence-Aware Guide Non-Invasive Light-Based Therapy Red & Near-Infrared Targeted Wavelengths Evidence-Aware Application Matters Sister Clinic: Luma Specialist PBM in Ireland Start With the Basics What Is Red Light Therapy? Red light therapy is a commonly used name for photobiomodulation, often shortened to PBM. PBM uses specific wavelengths of visible red light and near-infrared light delivered at controlled intensities and doses. You may also see terms such as low-level light therapy or low-level laser therapy used in the research. The aim is not to heat or damage tissue. Instead, photons are absorbed by light-sensitive molecules within cells, triggering biological responses that researchers are investigating across a wide range of applications. The important distinction:“Red light therapy” is a broad consumer term. Photobiomodulation is more precise. The wavelength, power, dose, treatment area, device, timing and condition being treated can all influence the biological effect. The Science How Can Light Affect a Cell? The leading mechanism involves absorption of red and near-infrared photons by cellular chromophores, including an enzyme in mitochondria called cytochrome c oxidase. Mitochondria are involved in producing ATP — the energy currency used by cells. Photobiomodulation appears capable of influencing mitochondrial activity and several downstream signalling pathways. The process is more complex than simply “boosting ATP”. Research also describes changes in reactive oxygen species signalling, nitric oxide, calcium signalling and gene expression. Photon Absorption Red and near-infrared photons can be absorbed by cellular photoreceptors, including mitochondrial cytochrome c oxidase. Mitochondrial Activity PBM may influence mitochondrial membrane potential, electron transport and ATP-related cellular energy processes. Cell Signalling Downstream signalling can involve nitric oxide, calcium, reactive oxygen species and transcription pathways. Biological Response These signals can influence processes such as cell migration, proliferation, inflammatory signalling and tissue response. Red vs Near-Infrared Why Wavelength Matters Not every red-light device delivers the same type of light. Different wavelengths interact differently with tissue, and this is one reason results from one device or protocol cannot automatically be applied to another. Red Light Typically around 620–700 nm Visible red wavelengths are commonly used in photobiomodulation applications involving skin and more superficial tissues. Near-Infrared Typically above 700 nm Near-infrared wavelengths are invisible to the eye and are often selected where greater tissue penetration is required. More penetration does not automatically mean better treatment.The right wavelength depends on the tissue and outcome being targeted. PBM is dose-dependent, and different applications require different treatment parameters. Where Is PBM Being Studied? The Evidence Depends on the Application Photobiomodulation has been studied for decades, but saying “red light therapy is clinically proven” is too broad. There is no single PBM outcome. Research differs substantially according to the condition, wavelength, device, dose and treatment schedule. Skin & Dermatology PBM has been investigated in areas including skin ageing, inflammatory skin conditions, wound response and dermatological recovery. Evidence varies by indication and protocol. Pain & Musculoskeletal Health Research includes musculoskeletal pain, joints, tendons and soft-tissue applications. Results are not uniform across every condition or treatment protocol. Exercise & Recovery PBM has been studied in exercise performance and muscle recovery. Reviews suggest potential in some areas, but protocol variability remains a major issue. Neurological Research Red and near-infrared light are also being investigated in neurological and brain-related research, but many applications remain experimental or emerging. An Example of Why Context Matters PBM & Exercise Recovery Exercise recovery is a useful example of why broad claims about red light therapy can be misleading. Whole-body PBM has become increasingly popular in sports and recovery settings, but a 2025 systematic review noted that protocols and methodologies varied considerably between studies. 2025 Systematic Review Whole-Body Photobiomodulation & Exercise Researchers reviewed whole-body PBM in relation to exercise performance and recovery. The field showed potential, but differences in devices, wavelengths, doses and study methods made firm conclusions difficult. This is a recurring issue in PBM research: the words “red light therapy” can describe interventions that are technically very different. View the Review on PubMed → 2025 Systematic Review & Meta-Analysis Muscle Recovery Another recent systematic review assessed photobiomodulation alongside other physical recovery interventions for muscle recovery. The findings add to the evidence base, but again highlight that treatment type and protocol matter. View the Research on PubMed → The Part Marketing Often Leaves Out Dose Matters as Much as the Colour of the Light A red-looking device is not enough to tell you whether it is delivering an appropriate photobiomodulation treatment. Researchers describe PBM as having wavelength- and dose-dependent effects. In practical terms, several variables matter. Wavelength Determines which light is being delivered and how it interacts with tissue. Irradiance Describes the amount of optical power reaching a given area. Energy Dose Depends on both intensity and treatment time. Longer is not automatically better. Treatment Area A small local laser treatment and a large-area light device are not equivalent simply because both use red or near-infrared light. Frequency Treatment schedules vary considerably between research protocols and intended applications. LED vs Laser The light source is one part of the treatment — not the whole story. Is a Laser Better Than an LED Panel? Both LEDs and low-level lasers can be used for photobiomodulation. They deliver light differently, and the appropriate option depends on the treatment objective. A targeted laser may be selected for a focused area, whereas larger LED or multi-diode systems can cover a broader treatment area. The important comparison is not simply “laser versus LED”. It is the combination of wavelength, power, dose, treatment area, tissue depth and intended biological outcome. Why this matters when buying a home device Consumer products vary substantially. A product being red, near-infrared or marketed as “medical grade” does not by itself establish that it matches the protocol used in a published study. Safety Is Red Light Therapy Safe? PBM is generally described as a non-invasive light therapy and does not work by heating or deliberately damaging tissue. That said, appropriate use still matters. Devices can differ in power and wavelength, and eye protection or other precautions may be relevant depending on the equipment and treatment area. People receiving medical treatment, taking photosensitising medications, managing significant health conditions or considering treatment over a suspicious skin lesion should seek appropriate professional advice. “Non-invasive” does not mean “use anything, at any dose”. The aim should be an appropriate treatment for a defined purpose, not simply the maximum light exposure available. Dedicated Red Light Therapy Looking for Photobiomodulation Treatment in Ireland? ReWell's core specialist area is Hyperbaric Oxygen Therapy. For dedicated red light and laser-based photobiomodulation, we recommend our sister clinic, Luma Health. Luma specialises in photobiomodulation and light-based therapy, including targeted low-level laser therapy and broader-area GigaLaser treatment. Its team works across areas including recovery, pain, women's health and fertility support, with treatments delivered through dedicated PBM services. Our Sister Site Explore Red Light Therapy at Luma Health If red light therapy is the treatment you are specifically interested in, Luma is the best place to learn more about the technology, treatment options and current clinic services. Visit Luma Health Explore Luma Photobiomodulation Different Technologies Red Light Therapy & HBOT Are Not the Same Thing Both technologies appear in recovery and wellness settings, but they work through fundamentally different physical mechanisms. PBM Uses Light Red and near-infrared photons interact with cellular photoreceptors and influence mitochondrial and downstream signalling pathways. HBOT Uses Pressure + Oxygen Hyperbaric Oxygen Therapy increases ambient pressure and oxygen exposure, increasing the amount of oxygen dissolved in blood plasma during treatment. One should not be described as a substitute for the other. Whether either technology is relevant depends on the person's goal, condition and individual circumstances. Continue Exploring Learn More How Hyperbaric Oxygen Therapy Works → Explore ReWell's HBOT Research → Photobiomodulation at Luma → Explore the Luma Blog → Selected Research References Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol. 2018. PubMed Hamblin MR. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. PubMed Photobiomodulation CME Part I: Overview and Mechanism of Action. 2024. PubMed Álvarez-Martínez M, Borden G. A systematic review on whole-body photobiomodulation for exercise performance and recovery. Lasers Med Sci. 2025. PubMed Canez MS, et al. Effects of photobiomodulation, intermittent pneumatic compression and neuromuscular electrical stimulation on muscle recovery: systematic review with meta-analysis. 2025. PubMed Common Questions Red Light Therapy FAQs What is red light therapy? Red light therapy is a common name for photobiomodulation, a non-invasive treatment that uses specific red and near-infrared wavelengths to influence biological activity in cells and tissues. Is red light therapy the same as photobiomodulation? The terms are often used interchangeably, although photobiomodulation is the more precise scientific term. PBM can include both visible red and near-infrared wavelengths and can be delivered by LEDs or low-level lasers. How does red light therapy work? One of the main proposed mechanisms involves absorption of light by mitochondrial cytochrome c oxidase. This can influence mitochondrial activity and downstream cellular signalling involving ATP, nitric oxide, reactive oxygen species and calcium. Does red light therapy increase ATP? PBM can influence mitochondrial bioenergetics and ATP-related processes, but describing the treatment simply as an “ATP booster” leaves out much of the biology. Dose, wavelength and the state of the tissue all influence the response. Is near-infrared light better than red light? Not automatically. Near-infrared light generally penetrates tissue differently from visible red light, but the appropriate wavelength depends on the tissue, device and treatment objective. Can I use a home red light device? Home devices are widely available, but their wavelengths, irradiance, treatment area and dose can vary substantially. A consumer product should not be assumed to reproduce the protocol used in a clinical study simply because it emits red or near-infrared light. Where can I access red light therapy in Ireland? ReWell's sister clinic, Luma Health, specialises in photobiomodulation and light-based therapies in Ireland. You can learn more about its current services at Luma.ie . The Bottom Line Red Light Therapy Is More Than the Colour of the Light Photobiomodulation is a genuine area of biomedical research with plausible cellular mechanisms and a growing evidence base across a range of applications. But the category is broad. Different wavelengths, devices, doses and treatment protocols can produce different biological effects, and evidence from one application should not automatically be used to support another. The useful question is therefore not simply: “Does red light therapy work?” It is: “Which type of photobiomodulation, at what dose, for which outcome — and what does the evidence show for that particular use?” Dedicated Photobiomodulation Interested in Red Light or Laser Therapy? Visit our sister clinic Luma Health to explore dedicated photobiomodulation, red light and laser-based treatments in Ireland. Visit Luma Health This article is provided for general educational information only and does not constitute medical advice, diagnosis or treatment. Photobiomodulation research varies substantially according to wavelength, dose, device, treatment area and condition being studied. A result from one protocol or clinical application should not be assumed to apply to every red-light device or use. Individual suitability should be considered before beginning a new light-based therapy.